These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1026816)

  • 21. Ofloxacin containing combined drug regimens in the treatment of multibacillary leprosy.
    Sampoonachot P; Bundit C; Kuhacharoen N; Peerapakorn S; Kampirapap K; Poomlek A; Bampenyu S; Tiasiri S; Rungruang S; Surasondhi S; Supanwanit S; Wiriyawipart S
    Southeast Asian J Trop Med Public Health; 1997 Dec; 28(4):803-10. PubMed ID: 9656405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotherapy trial with a triple-drug regimen, including once-monthly Rimactane (Rifampicin), in patients with multibacillary types of leprosy.
    Reyes-Javier PD; Tantiongco PR
    Acta Leprol; 1983; 1(3):133-41. PubMed ID: 6359801
    [No Abstract]   [Full Text] [Related]  

  • 23. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results.
    Mane I; Cartel JL; Grosset JH
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):224-9. PubMed ID: 9251595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined chemotherapy trials with regimens containing ofloxacin and rifampicin for multibacillary leprosy patients.
    Sampoonachot P; Bundit C; Kuhacharoen N; Peerapakorn S; Kampirapap K; Poomlek A; Bampenyu S; Tiasiri S; Rungruang S; Surasondhi S; Supanwanit S; Wiriyawipart S
    J Med Assoc Thai; 1996 Apr; 79(4):210-7. PubMed ID: 8708505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of multidrug therapy with rifampicin, clofazimine and D.D.S. in multibacillary leprosy cases.
    Kundu SK; Hazra SK; Chaudhury S; Chatterjee B
    Indian J Lepr; 1984; 56(1):78-85. PubMed ID: 6548246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Efficacy of a daily dosage of dapsone combined with a single dose of rifampicin. Clinical, bacteriological and histopathological evaluation].
    Le KD; Nguyen N; Nguyen VM
    Acta Leprol; 1981; 85():75-82. PubMed ID: 6805238
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of two multidrug regimen in hospitalised multibacillary cases.
    Chattopadhyay SP; Gupta CM; Bhate RD; Bhate RP; Sreevatsa
    Indian J Lepr; 1989 Apr; 61(2):196-205. PubMed ID: 2746028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Resistance of Mycobacterium leprae to sulfones (DDS) and rifampicin in recurring lepromatous leprosy in Martinique and Guadeloupe since February 1980].
    Guelpa-Lauras CC; Constant-Desportes M; Millan J; Grosset J
    Acta Leprol; 1982; (86-87):77-80. PubMed ID: 6816000
    [No Abstract]   [Full Text] [Related]  

  • 29. [Therapeutic effect of rifampicin (RFP) on leprosy. I. Clinical effect (observation of twelve months) (author's transl)].
    Repura; 1974; 43(1):8-25. PubMed ID: 4479678
    [No Abstract]   [Full Text] [Related]  

  • 30. Flu like syndrome with rifampicin pulse therapy.
    Parking AA; Shah BH
    Indian J Lepr; 1989 Apr; 61(2):209-10. PubMed ID: 2746030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Tuberculoid leprosy treated with rifampicin].
    Guilaine J; Stérin D; Després E; Lesobre R
    Bull Soc Fr Dermatol Syphiligr; 1969; 76(6):749-50. PubMed ID: 5384187
    [No Abstract]   [Full Text] [Related]  

  • 32. Therapy of leprosy with rifampicin.
    Wilkinson FF; Gago J; Santabaya E
    Int J Lepr Other Mycobact Dis; 1972; 40(1):53-7. PubMed ID: 4672996
    [No Abstract]   [Full Text] [Related]  

  • 33. [Resistance of Mycobacterium leprae to dapsone and rifampicin: apropos of a survey carried out in the Cape Verde region (Senegal)].
    Grosset J; Guelpa-Lauras CC; Millan J; Bodian M; Perani E
    Med Trop (Mars); 1987; 47(2):171-5. PubMed ID: 3306248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical trial of pefloxacin and ofloxacin in the treatment of lepromatous leprosy.
    Grosset JH; Ji BH; Guelpa-Lauras CC; Perani EG; N'Deli LN
    Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):281-95. PubMed ID: 2198315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The activity of rifabutin against Mycobacterium leprae.
    Yoder LJ; Jacobson RR; Hastings RC
    Lepr Rev; 1991 Sep; 62(3):280-7. PubMed ID: 1665534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of probenecid on serum rifampicin levels.
    Pankaj R; Lal S; Rao RS
    Indian J Lepr; 1985; 57(2):329-33. PubMed ID: 4078358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rifampicin in the treatment of reactions in leprosy.
    Rampen F
    Lepr Rev; 1976 Mar; 47(1):75-6. PubMed ID: 1263737
    [No Abstract]   [Full Text] [Related]  

  • 38. [1st results of the treatment of leprosy with rifampicin in New Caledonia].
    Chanalet G; Guyon J; Beaute J; Parc F; Boutier F
    Med Trop (Mars); 1972; 32(2):203-15. PubMed ID: 5082187
    [No Abstract]   [Full Text] [Related]  

  • 39. A comparative trial of single dose chemotherapy in paucibacillary leprosy patients with two to three skin lesions.
    2-3 Lesion Multicentre Trial Group
    Indian J Lepr; 2001; 73(2):131-43. PubMed ID: 11579649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minimum inhibitory and bactericidal dosages of rifampici against Mycobacterium leprae in the mouse foot pad: relationship to serum rifampicin concentrations.
    Holmes IB
    Int J Lepr Other Mycobact Dis; 1974; 42(3):289-96. PubMed ID: 4617716
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.